Increased Hsp90α/β protein expression in primary CRC (pCRC) is an independent factor for poor prognosis in a substantial number of patients in a locally advanced and metastatic stage (UICC IIB-IV). This evidence concerns the gene HSP90AA1 and colorectal carcinoma.